Botsios, C., et al. “Anakinra, a Recombinant Human IL-1 Receptor Antagonist, in Clinical Practice. Outcome in 60 Patients With Severe Rheumatoid Arthritis”. Reumatismo, vol. 59, no. 1, Mar. 2007, pp. 32-37, doi:10.4081/reumatismo.2007.32.